Alvotech(us:ALVO)
12.60
+5.79%
Updated on 2024-12-23
Open:12.49
Close:12.60
High:12.63
Low:12.30
Pre Close:11.91
Volume:77495.00
Amount:972289.88
Turnover:0.03%
Shares:301.94M
MarketCap:3.80B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 33 | 14961045 | 5.35% | 11 | 5 | 12 |
| 2024-03-31 | 26 | 14260114 | 5.10% | 8 | 7 | 8 |
| 2023-12-31 | 21 | 17435947 | 6.53% | 2 | 6 | 6 |
| 2023-09-30 | 21 | 17769791 | 6.68% | 4 | 4 | 9 |
| 2023-06-30 | 20 | 17553503 | 6.60% | 3 | 4 | 8 |
| 2023-03-31 | 19 | 23955901 | 9.13% | 7 | 3 | 5 |
| 2022-12-31 | 15 | 19215429 | 7.73% | 1 | 0 | 6 |
| 2022-09-30 | 19 | 20765079 | 8.35% | 1 | 2 | 8 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 3125784 | 1.12% | 63948 | 2.09% |
| 2024-03-31 | Oaktree Capital Management Lp | 2899201 | 1.04% | -2551695 | -46.81% |
| 2024-03-31 | Bracebridge Capital, Llc | 2705304 | 0.97% | -1655220 | -37.96% |
| 2024-03-31 | Sculptor Capital Lp | 1946162 | 0.70% | 859815 | 79.15% |
| 2024-03-31 | Littlejohn & Co Llc | 1218534 | 0.44% | 86143 | 7.61% |
| 2024-03-31 | Morgan Stanley | 825601 | 0.30% | 825575 | 3175288.46% |
| 2024-03-31 | Lodbrok Capital Llp | 751408 | 0.27% | 107363 | 16.67% |
| 2024-03-31 | Marshall Wace, Llp | 250123 | 0.09% | 250123 | |
| 2024-03-31 | Oaktree Fund Advisors, Llc | 136051 | 0.05% | -387864 | -74.03% |
| 2024-03-31 | Geode Capital Management, Llc | 132996 | 0.05% | 68331 | 105.67% |
About
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
Address:9, rue de Bitbourg
Website:http://www.alvotech.com
Market Movers